You are here

Medical - global

Primary tabs

The medical working group is focused on issues that affect delivery of medical care to those in need

The medical working group seeks to address issues affecting delivery of medical care to those in need.

Members

Dr Ojia Adamolekun LadyCath mike kraft

Email address for group

medical-global@m.resiliencesystem.org

COVID's indirect effects may have affected people with Alzheimer's and dementia more than others

Excess mortality was twice as high for older adults with dementia in the early phase of the COVID-19 pandemic than it was for those without dementia, an analysis of all Medicare enrollees showed.

From March through December 2020, adjusted mortality was 25.7% higher (95% CI 25.3-26.2) among older adults with Alzheimer's disease and related dementias than it was during a similar period in 2019, reported Lauren Gilstrap, MD, MPH, of Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire, and co-authors.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

New Data indicates Pfizer Covid vaccine is less effective in kids 5 to 11

Newly emerging data suggest the Pfizer-BioNTech Covid vaccine works substantially less well at preventing infection and hospitalizations in children aged 5 to 11 than it does in those aged 12 to 17 — a finding that is raising questions about whether the companies chose the wrong dose for the younger children.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Overview: Asia developments, Hong Kong, South Korea, China vaccine situation

Feb 28 (Reuters) --  ...

Hong Kong mortuaries hit capacity

 -- Facilities for storing dead bodies at hospitals and public mortuaries in Hong Kong are at maximum capacity due to a record number of COVID-19 fatalities, the Hospital Authority said on Monday, as officials battle to control a surge in cases.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

CDC STAFF explains Why Lengthen mRNA Vaccine Dosing Interval

Extended dosing intervals for Pfizer or Moderna vaccines may be considered for certain individuals ages 12 to 64 years, not only to lower the risk of vaccine-associated myocarditis, but to potentially improve vaccine effectiveness, CDC staff said on Thursday.

According to the agency's new interim guidance, young people ages 12 to 39 may especially benefit from a second mRNA dose 8 weeks after their first dose.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

howdy folks
Page loaded in 2.525 seconds.